Back to search

Boston University

Exploring the benefits of prenatal aspirin in patients at risk for preeclampsia at Boston Medical Center

Abstract

dc:description.abstract

BACKGROUND: Preeclampsia is one of the leading causes of maternal and perinatal morbidity and mortality, affecting 2-8% of pregnancies worldwide. It is estimated that 76,000 women and 500,000 babies die from this disease each year globally. Preeclampsia is characterized as hypertension associated with the onset of proteinuria, maternal organ dysfunction or uteroplacental dysfunction occurring at or after 20 weeks of gestation. In addition to its effects on pregnancy, preeclampsia may also have long-term adverse effects on women who experience the disorder and their children later on in life. Currently, the only cure for preeclampsia is delivery, which is often associated with preterm birth, increasing the risk of neonatal death. Daily low-dose aspirin (81mg) has been shown to have a preventive effect on preeclampsia in women at high risk of developing the disorder. OBJECTIVE: To analyze patient data collected at Boston Medical Center to determine the effects of prescribed low dose prenatal aspirin (81 mg) on pregnancy outcomes. METHODS: There were 2648 obstetric deliveries at Boston Medical Center in the two-year span of 2017-2018. Using R, statistical analyses were performed to determine the difference in birth outcomes between the prenatal aspirin prescribed group and the non-aspirin prescribed group as well as the effect of prenatal aspirin on pregnancy outcomes. Logarithmic and linear models as well as basic statistical methods were employed for the analyses. RESULTS: The prenatal aspirin prescribed population had higher major and moderate risk factors as well as worse birth outcomes, Apgar scores and birthweight as compared with the non-prescribed population. However, prenatal aspirin may reduce the adverse effects of both major and moderate risk factors on birth outcomes. CONCLUSIONS: Prenatal aspirin may have beneficial effects on birth outcomes, and the pregnant population at Boston Medical Center may benefit from taking low-dose aspirin. This study was carried out retrospectively with a cohort that was not randomized, so this conclusion needs to be verified by future studies.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Zhao, Tony
Advisor dc:contributor.advisor
  • Abbott, Jodi

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/41784

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Zhao, Tony. Exploring the benefits of prenatal aspirin in patients at risk for preeclampsia at Boston Medical Center. masters thesis, Boston University, 2020. https://hdl.handle.net/2144/41784